Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Stojanovski, J. Minov, S. Ivanov (Skopje, Kumanovo, Fyrom). Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity. Eur Respir J 2009; 34: Suppl. 53, 516

Member's Comments

No comment yet.

Related content which might interest you: The food frequency in patients with chronic obstructive pulmonary disease: effect of exacerbation of disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Are severe asthma and chronic obstructive pulmonary disease the same disease? Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006 Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Angiogenic status in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Effects of severity of chronic obstructive pulmonary disease on thyroid function Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Systemic inflammation, quality of life and comorbidity in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 Is pain a risk factor for symptom severity in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020